Cancer is the leading cause of death for Americans between the ages of 40 and 79. Lung cancer is the leading cause of cancer death for both men and women in the US.

Lung cancer is the world's deadliest cancer. It kills more Americans than the next three cancers combined - breast, prostate and colon - at half the incidence rate.

About Orbit Genomics

Orbit Genomics was founded to accelerate precision medicine through its analysis and exploitation of the hidden genome.


Orbit Genomics’  technology platform is being used to develop products which will significantly improve patient outcomes.

Contact Us

For more information on our  products and services,   or if you would  like copies of our publications,   please contact us.

Unlocking the Hidden Genome

Learn More



Since the first sequencing of the human genome in 2003, tremendous gains have been made in understanding hereditary cancer syndromes, with over 50 having been identified. Non-invasive tests to assess a person’s inherited risk of developing certain cancers are abundant. However, the clinical utility of these tests is limited. Orbit Genomics’  OrbiSeq technology platform is based on novel DNA markers called microsatellites. Microsatellites are much more responsive than other genomic markers, providing personalized disease risk. They are your DNA’s early warning system.

  • Science & Technology

    Accelerating precision medicine by developing clinically actionable tests.

  • Product Pipeline

    Improving lung cancer diagnosis.

  • About Us

    Founded in 2016 as a collaboration between Dr. Harold “Skip” Garner and Ventac Partners.

  • Contact Us

    +1 720.515.0395


CSO, Skip Garner, in the News

Researchers in Blacksburg Develop Lung Cancer Risk Genetic Test

Microsatellite Genotyping in Lung Cancer

Orbit Genomics Co-Founder and CSO, Dr. Harold “Skip” Garner, is the senior author on a paper appearing in Oncogene (31 July 2017) entitled “High-depth, high-accuracy microsatellite genotyping enables precision lung cancer risk classification” and can be viewed at Early detection and screening for lung cancer can help overcome the high incidence and poor survival rates […]

Science in Genomic Medicine

With the launch of the precision medicine cohort initiative, All of UsSM  Research Program, the importance of incorporating implementation science in genomic medicine is greater than ever to ensure population health benefits for all. Historically, the speed of genomic discovery has far exceeded the time required to put these potentially life-saving medical discoveries into practice. […]